Magna Strategies provides structured CBAM review and evidence governance support for companies that need to understand their exposure, assess evidence readiness, and decide what to do next.
Step 1 — Review
A focused review to determine whether a commercially meaningful CBAM issue exists, how prepared your current evidence base is, and what the most sensible next step should be.
Typical output may include:
- exposure view
- evidence readiness view
- recommended next step
Step 2 — Pilot
A limited supplier-side pilot designed to test whether evidence governance can work in practice with selected suppliers.
Step 3 — Documentation
Selective follow-on support for cases where additional documentation work is justified after the initial review.
How the product path works
Step 1 clarifies whether a meaningful issue exists and where further work is most justified.
Step 2 tests how evidence governance may work in practice with selected suppliers.
Step 3 supports additional documentation work where further effort is warranted.